Skip to main content

Table 1 Baseline information before second-line antiretroviral treatment

From: Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China

Variable Category Numerical value
Gender (n. %) Male 73(60.8%)
Female 47(39.2%)
Age (years, IQR)   45.2(39.8–52.3)
Education degree (n, %) Primary school 61(50.8%)
Junior middle school 40(33.3%)
Illiteracy 19(15.8%)
Occupation (n, %) Farmer 120(100%)
Route of infection (n, %) Paid blood donation(blood transfusion) 115(95.8%)
Heterosexual 3(2.5%)
Blood transfusion 1(0.8%)
Unknown 1(0.8%)
Duration of first-line treatment (years, IQR)   5.0(3.7–5.5)
NRTIs drug resistance (n, %)   68(58.1%)
  3TC drug resistance 38(32.5%)
  TDF drug resistance 57(48.7%)
NNRTIs drug resistance (n, %)   84(71.8%)
Lpv/r drug resistance (n, %)   0(0)
Baseline viral load (lg10) (median, IQR) copies/ml   4.58 (3.96–5.17)
Baseline CD4 + T cells (median, IQR) cells/μl   170 (100–272)
  1. 3TC Lamivudine, TDF Tenofovir, NRTIs Nucleoside reverse transcriptase inhibitor, NNRTIs Non-nucleoside reverse transcriptase inhibitor, Lpv/r Lopinavir/ritonavir